NYSEARCA:SBIOALPS Medical Breakthroughs ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $42.03 -0.35 (-0.83 %) (As of 07/13/2020 04:00 PM ET) Add Share Today's Range$41.92Now: $42.03▼$42.6450-Day Range$39.51MA: $42.02▼$44.1452-Week Range$25.10Now: $42.03▼$45.02Volume13,700 shsAverage Volume57,254 shsMarket Capitalization$191.24 millionP/E RatioN/ADividend Yield0.04%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media Geographic Exposure of SBIOCurrency Exposure of SBIOSector Exposure of SBIOIndustry Exposure of SBIO Basic Details Issuer Alps Fund NameALPS Medical Breakthroughs ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:SBIO Inception Date12/31/2014 Fund ManagerRyan Mischker, Andrew Hicks WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkPoliwogg Medical Breakthroughs Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$191.46 million Average Daily Volume$30,974.70 Discount/Premium-0.05% ETF Expenses Management Fee0.50% Other Expenses0.00% Total Expenses0.50% Fee Waiver0.00% Net Expenses0.50%Administrator, Advisor and Custodian AdministratorALPS Fund Services, Inc. AdvisorALPS Advisors, Inc. CustodianState Street Bank and Trust Company DistributorALPS Portfolio Solutions Distributor, Inc. Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerCantor Fitzgerald AMEX:SBIO Rates by TradingView Receive SBIO News and Ratings via Email Sign-up to receive the latest news and ratings for SBIO and its competitors with MarketBeat's FREE daily newsletter. ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Frequently Asked Questions How has ALPS Medical Breakthroughs ETF's stock been impacted by COVID-19 (Coronavirus)? ALPS Medical Breakthroughs ETF's stock was trading at $33.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SBIO stock has increased by 25.1% and is now trading at $42.03. View which stocks have been most impacted by Coronavirus. How often does ALPS Medical Breakthroughs ETF pay dividends? What is the dividend yield for ALPS Medical Breakthroughs ETF? ALPS Medical Breakthroughs ETF announced an annual dividend on Thursday, December 19th. Shareholders of record on Friday, December 20th will be given a dividend of $0.0159 per share on Friday, December 27th. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, December 19th. View ALPS Medical Breakthroughs ETF's dividend history. Has ALPS Medical Breakthroughs ETF been receiving favorable news coverage? News stories about SBIO stock have trended very negative on Monday, according to InfoTrie. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ALPS Medical Breakthroughs ETF earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about ALPS Medical Breakthroughs ETF. What other stocks do shareholders of ALPS Medical Breakthroughs ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Marina Biotech (MRNA), Novavax (NVAX), Sanofi (SNY), Walmart (WMT) and Cidara Therapeutics (CDTX). What is ALPS Medical Breakthroughs ETF's stock symbol? ALPS Medical Breakthroughs ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "SBIO." Who are ALPS Medical Breakthroughs ETF's major shareholders? ALPS Medical Breakthroughs ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Summit Financial Group Inc. (0.18%) and Envestnet Asset Management Inc. (0.13%). Which major investors are buying ALPS Medical Breakthroughs ETF stock? SBIO stock was bought by a variety of institutional investors in the last quarter, including Summit Financial Group Inc., and Envestnet Asset Management Inc.. How do I buy shares of ALPS Medical Breakthroughs ETF? Shares of SBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ALPS Medical Breakthroughs ETF's stock price today? One share of SBIO stock can currently be purchased for approximately $42.03. How big of a company is ALPS Medical Breakthroughs ETF? ALPS Medical Breakthroughs ETF has a market capitalization of $191.24 million. This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
